메뉴 건너뛰기




Volumn 6, Issue 2, 2014, Pages 179-204

Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands

Author keywords

[No Author keywords available]

Indexed keywords

2 THIAZOLIDINONE; 3,5 DIMETHYLISOXAZOLE; BINDING PROTEIN; CPI 0610; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; I BET 762; ISOXAZOLE DERIVATIVE; LIGAND; LYSINE; OTX 015; RVX 208; SMALL MOLECULE BROMODOMAIN LIGAND; UNCLASSIFIED DRUG;

EID: 84893200428     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.197     Document Type: Review
Times cited : (27)

References (90)
  • 1
    • 14744276712 scopus 로고    scopus 로고
    • Selective small molecules blocking HIV-1 Tat and coactivator PCAF association
    • Zeng L, Li J, Muller M et al. Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J. Am. Chem. Soc. 127(8), 2376-2377 (2005
    • (2005) J. Am. Chem. Soc , vol.127 , Issue.8 , pp. 2376-2377
    • Zeng, L.1    Li, J.2    Muller, M.3
  • 2
    • 30744456492 scopus 로고    scopus 로고
    • Target structure-based discovery of small molecules that block human p53 and CREB binding protein association
    • Sachchidanand, Resnick-Silverman L, Yan S et al. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem. Biol. 13(1), 81-90 (2006
    • (2006) Chem. Biol , vol.13 , Issue.1 , pp. 81-90
    • Sachchidanand Resnick-Silverman, L.1    Yan, S.2
  • 3
    • 78650806593 scopus 로고    scopus 로고
    • Suppression of inflammation by a synthetic histone mimic
    • Nicodeme E, Jeffrey KL, Schaefer U et al. Suppression of inflammation by a synthetic histone mimic. Nature 468(7327), 1119-1123 (2010
    • (2010) Nature , vol.468 , Issue.7327 , pp. 1119-1123
    • Nicodeme, E.1    Jeffrey, K.L.2    Schaefer, U.3
  • 4
    • 79958078949 scopus 로고    scopus 로고
    • Discovery and characterization of small molecule inhibitors of the BET family bromodomains
    • Chung C-W, Coste H, White JH et al. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J. Med. Chem. 54(11), 3827-3838 (2011
    • (2011) J. Med. Chem , vol.54 , Issue.11 , pp. 3827-3838
    • Chung, C.-W.1    Coste, H.2    White, J.H.3
  • 5
    • 77952713824 scopus 로고    scopus 로고
    • RVX-208: A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo
    • Bailey D, Jahagirdar R, Gordon A et al. RVX-208: A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J. Am. Coll. Cardiol. 55(23), 2580-2589 (2010
    • (2010) J. Am. Coll. Cardiol , vol.55 , Issue.23 , pp. 2580-2589
    • Bailey, D.1    Jahagirdar, R.2    Gordon, A.3
  • 6
    • 84877085080 scopus 로고    scopus 로고
    • In vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7- dimethoxyquinazolin-4(3H)-one (RVX-208
    • Khmelnitsky YL, Mozhaev VV, Cotterill IC et al. In vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2- hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208). Eur. J. Med. Chem. 64C, 121-128 (2013
    • (2013) Eur. J. Med. Chem. 64C , pp. 121-128
    • Khmelnitsky, Y.L.1    Mozhaev, V.V.2    Cotterill, I.C.3
  • 7
    • 78650847770 scopus 로고    scopus 로고
    • Selective inhibition of BET bromodomains
    • Filippakopoulos P, Qi J, Picaud S et al. Selective inhibition of BET bromodomains. Nature 468(7327), 1067-1073 (2010
    • (2010) Nature , vol.468 , Issue.7327 , pp. 1067-1073
    • Filippakopoulos, P.1    Qi, J.2    Picaud, S.3
  • 8
    • 84893189613 scopus 로고    scopus 로고
    • The BRD-inhibitor OTX015 shows pre-clinical activity in diffuse large B-cell lymphoma (DLBCL
    • Bonetti P, Ponzoni M, Tibiletti MG et al. The BRD-inhibitor OTX015 shows pre-clinical activity in diffuse large B-cell lymphoma (DLBCL). Eur. J. Cancer. 48(Suppl. 6), 163-163 (2012
    • (2012) Eur. J. Cancer , vol.48 , Issue.SUPPL. 6 , pp. 163-163
    • Bonetti, P.1    Ponzoni, M.2    Tibiletti, M.G.3
  • 9
    • 84893160224 scopus 로고    scopus 로고
    • The BRD-inhibitor OTX015 is active in pre-clinical models of mature B-cell lymphoid tumors
    • abstract 1657
    • Bonetti P, Boi M, Ponzoni M et al. The BRD-inhibitor OTX015 is active in pre-clinical models of mature B-cell lymphoid tumors. Blood 120(21), abstract 1657 (2012
    • (2012) Blood , vol.120 , Issue.21
    • Bonetti, P.1    Boi, M.2    Ponzoni, M.3
  • 10
    • 84886276286 scopus 로고    scopus 로고
    • The BRD-inhibitor OTX015 shows pre-clinical activity in anaplastic large T-cell lymphoma (ALCL
    • abstract 4872
    • Boi M, Bonetti P, Ponzoni M et al. The BRD-inhibitor OTX015 shows pre-clinical activity in anaplastic large T-cell lymphoma (ALCL). Blood 120(21), abstract 4872 (2012
    • (2012) Blood , vol.120 , Issue.21
    • Boi, M.1    Bonetti, P.2    Ponzoni, M.3
  • 11
    • 80054984945 scopus 로고    scopus 로고
    • Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia
    • Dawson MA, Prinjha RK, Dittmann A et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia. Nature 478(7370), 529-533 (2011
    • (2011) Nature , vol.478 , Issue.7370 , pp. 529-533
    • Dawson, M.A.1    Prinjha, R.K.2    Dittmann, A.3
  • 12
    • 84856397832 scopus 로고    scopus 로고
    • Fragment-based discovery of bromodomain inhibitors part 1: Inhibitor binding modes and implications for lead discovery
    • Chung C-W, Dean AW, Woolven JM, Bamborough P. Fragment-based discovery of bromodomain inhibitors part 1: Inhibitor binding modes and implications for lead discovery. J. Med. Chem. 55(2), 576-586 (2012
    • (2012) J. Med. Chem , vol.55 , Issue.2 , pp. 576-586
    • Chung, C.-W.1    Dean, A.W.2    Woolven, J.M.3    Bamborough, P.4
  • 13
    • 84856399470 scopus 로고    scopus 로고
    • Fragment-based discovery of bromodomain inhibitors part 2: Optimization of phenylisoxazole sulfonamides
    • Bamborough P, Diallo H, Goodacre JD et al. Fragment-based discovery of bromodomain inhibitors part 2: Optimization of phenylisoxazole sulfonamides. J. Med. Chem. 55(2), 587-596 (2012
    • (2012) J. Med. Chem , vol.55 , Issue.2 , pp. 587-596
    • Bamborough, P.1    Diallo, H.2    Goodacre, J.D.3
  • 14
    • 80053924872 scopus 로고    scopus 로고
    • 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
    • Hewings DS, Wang M, Philpott M et al. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 54(19), 6761-6770 (2011
    • (2011) J. Med. Chem , vol.54 , Issue.19 , pp. 6761-6770
    • Hewings, D.S.1    Wang, M.2    Philpott, M.3
  • 15
    • 84871738620 scopus 로고    scopus 로고
    • The design and synthesis of 5 and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
    • Hay D, Fedorov O, Filippakopoulos P et al. The design and synthesis of 5 and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains. Med. Chem. Commun. 4, 140-144 (2013
    • (2013) Med. Chem. Commun , vol.4 , pp. 140-144
    • Hay, D.1    Fedorov, O.2    Filippakopoulos, P.3
  • 16
    • 84876833549 scopus 로고    scopus 로고
    • Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands
    • Hewings DS, Fedorov O, Filippakopoulos P et al. Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. J. Med. Chem. 56(8), 3217-3227 (2013
    • (2013) J. Med. Chem , vol.56 , Issue.8 , pp. 3217-3227
    • Hewings, D.S.1    Fedorov, O.2    Filippakopoulos, P.3
  • 17
    • 84870046749 scopus 로고    scopus 로고
    • Identification of a chemical probe for bromo and extra c-Terminal bromodomain inhibition through optimization of a fragment-derived hit
    • Fish PV, Filippakopoulos P, Bish G et al. Identification of a chemical probe for bromo and extra c-Terminal bromodomain inhibition through optimization of a fragment-derived hit. J. Med. Chem. 55(22), 9831-9837 (2012
    • (2012) J. Med. Chem , vol.55 , Issue.22 , pp. 9831-9837
    • Fish, P.V.1    Filippakopoulos, P.2    Bish, G.3
  • 18
    • 84878029292 scopus 로고    scopus 로고
    • Fragment-based drug discovery of 2-Thiazolidinones as inhibitors of the histone reader BRD4 bromodomain
    • Zhao L, Cao D, Chen T et al. Fragment-based drug discovery of 2-Thiazolidinones as inhibitors of the histone reader BRD4 bromodomain. J. Med. Chem. 56(10), 3833-3851 (2013
    • (2013) J. Med. Chem , vol.56 , Issue.10 , pp. 3833-3851
    • Zhao, L.1    Cao, D.2    Chen, T.3
  • 19
    • 83455202613 scopus 로고    scopus 로고
    • Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions
    • Chung C-W, Witherington J. Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions. J. Biomol. Screen. 16(10), 1170-1185 (2011
    • (2011) J. Biomol. Screen , vol.16 , Issue.10 , pp. 1170-1185
    • Chung, C.-W.1    Witherington, J.2
  • 20
    • 84871420585 scopus 로고    scopus 로고
    • Bromodomains: A new target class for small molecule drug discovery
    • Chung C-W, Tough DF. Bromodomains: A new target class for small molecule drug discovery. Drug Discov. Today: Ther. Strateg. 9,(2-3), e111-e120 (2012
    • (2012) Drug Discov. Today: Ther. Strateg , vol.9 , Issue.2-3
    • Chung, C.-W.1    Tough, D.F.2
  • 21
    • 84862817809 scopus 로고    scopus 로고
    • Place your BETs: The therapeutic potential of bromodomains
    • Prinjha RK, Witherington J, Lee K. Place your BETs: The therapeutic potential of bromodomains. Trends Pharmacol. Sci. 33(3), 146-153 (2012
    • (2012) Trends Pharmacol. Sci , vol.33 , Issue.3 , pp. 146-153
    • Prinjha, R.K.1    Witherington, J.2    Lee, K.3
  • 22
    • 84866353161 scopus 로고    scopus 로고
    • Bromodomains: Are readers right for epigenetic therapy?
    • Conway SJ. Bromodomains: Are readers right for epigenetic therapy? ACS Med. Chem. Lett. 3, 691-694 (2012
    • (2012) ACS Med. Chem. Lett , vol.3 , pp. 691-694
    • Conway, S.J.1
  • 24
    • 84870013141 scopus 로고    scopus 로고
    • Progress in the development and application of small molecule inhibitors of bromodomain-Acetyl-lysine interactions
    • Hewings DS, Rooney TPC, Jennings LE et al. Progress in the development and application of small molecule inhibitors of bromodomain-Acetyl-lysine interactions. J. Med. Chem. 55(22), 9393-9413 (2012
    • (2012) J. Med. Chem , vol.55 , Issue.22 , pp. 9393-9413
    • Hewings, D.S.1    Rooney, T.P.C.2    Jennings, L.E.3
  • 25
    • 84857331171 scopus 로고    scopus 로고
    • Inhibition of bromodomain-mediated protein-protein interactions as a novel therapeutic strategy
    • Furdas SD, Carlino L, Sippl W, Jung M. Inhibition of bromodomain-mediated protein-protein interactions as a novel therapeutic strategy. Med. Chem. Commun. 3(2), 123-134 (2012
    • (2012) Med. Chem. Commun , vol.3 , Issue.2 , pp. 123-134
    • Furdas, S.D.1    Carlino, L.2    Sippl, W.3    Jung, M.4
  • 26
    • 77951218846 scopus 로고    scopus 로고
    • Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain
    • Umehara T, Nakamura Y, Jang MK et al. Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem. 285(10), 7610-7618 (2010
    • (2010) J. Biol. Chem , vol.285 , Issue.10 , pp. 7610-7618
    • Umehara, T.1    Nakamura, Y.2    Jang, M.K.3
  • 27
    • 84859443655 scopus 로고    scopus 로고
    • From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
    • Mirguet O, Lamotte Y, Donche F et al. From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151. Bioorg. Med. Chem. Lett. 22(8), 2963-2967 (2012
    • (2012) Bioorg. Med. Chem. Lett , vol.22 , Issue.8 , pp. 2963-2967
    • Mirguet, O.1    Lamotte, Y.2    Donche, F.3
  • 28
    • 84862809749 scopus 로고    scopus 로고
    • Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A
    • Seal J, Lamotte Y, Donche F et al. Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A). Bioorg. Med. Chem. Lett. 22(8), 2968-2972 (2012
    • (2012) Bioorg. Med. Chem. Lett , vol.22 , Issue.8 , pp. 2968-2972
    • Seal, J.1    Lamotte, Y.2    Donche, F.3
  • 29
    • 84896692123 scopus 로고    scopus 로고
    • Naphthyridines as novel BET family bromodomain inhibitors
    • doi:10.1002/cmdc.201300259 Epub ahead of print
    • Mirguet O, Lamotte Y, Chung C-W et al. Naphthyridines as novel BET family bromodomain inhibitors. ChemMedChem doi:10.1002/cmdc.201300259 (2013) (Epub ahead of print
    • (2013) Chem Med Chem
    • Mirguet, O.1    Lamotte, Y.2    Chung, C.-W.3
  • 30
    • 84859181036 scopus 로고    scopus 로고
    • Histone recognition and large-scale structural analysis of the human bromodomain family
    • Filippakopoulos P, Picaud S, Mangos M et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149(1), 214-231 (2012
    • (2012) Cell , vol.149 , Issue.1 , pp. 214-231
    • Filippakopoulos, P.1    Picaud, S.2    Mangos, M.3
  • 31
    • 84901196606 scopus 로고    scopus 로고
    • Epigenetic drugs that do not target enzyme activity
    • doi:10.1016-j.ddtec.10.008 In press
    • Owen DR, Trzupek JD. Epigenetic drugs that do not target enzyme activity. Drug Discov. Today Technol. doi:10.1016-j.ddtec.10.008 (2012) (In press
    • (2012) Drug Discov. Today Technol
    • Owen, D.R.1    Trzupek, J.D.2
  • 32
    • 69849089425 scopus 로고    scopus 로고
    • Synthesis at the interface of chemistry and biology
    • Wu X, Schultz PG. Synthesis at the interface of chemistry and biology. J. Am. Chem. Soc. 131(35), 12497-12515 (2009
    • (2009) J. Am. Chem. Soc , vol.131 , Issue.35 , pp. 12497-12515
    • Wu, X.1    Schultz, P.G.2
  • 33
    • 84857913614 scopus 로고    scopus 로고
    • Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
    • Filippakopoulos P, Picaud S, Fedorov O et al. Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family. Bioorg. Med. Chem. 20(6), 1878-1886 (2012
    • (2012) Bioorg. Med. Chem , vol.20 , Issue.6 , pp. 1878-1886
    • Filippakopoulos, P.1    Picaud, S.2    Fedorov, O.3
  • 34
    • 0033519641 scopus 로고    scopus 로고
    • JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain
    • Carlson
    • Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399(6735), 491-496 (1999
    • (1999) Nature , vol.399 , Issue.6735 , pp. 491-496
    • Dhalluin, C.1
  • 35
    • 0036206045 scopus 로고    scopus 로고
    • Structural basis of lysine-Acetylated HIV-1 Tat recognition by PCAF bromodomain
    • Mujtaba S, He Y, Zeng L et al. Structural basis of lysine-Acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell. 9(3), 575-586 (2002
    • (2002) Mol. Cell , vol.9 , Issue.3 , pp. 575-586
    • Mujtaba, S.1    He, Y.2    Zeng, L.3
  • 36
    • 34249027590 scopus 로고    scopus 로고
    • Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-Associated factor
    • Pan C, Mezei M, Mujtaba S et al. Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-Associated factor. J. Med. Chem. 50(10), 2285-2288 (2007
    • (2007) J. Med. Chem , vol.50 , Issue.10 , pp. 2285-2288
    • Pan, C.1    Mezei, M.2    Mujtaba, S.3
  • 37
    • 84876713208 scopus 로고    scopus 로고
    • Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication
    • Wang Q, Wang R, Zhang B, Zhang S, Zheng Y, Wang Z. Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication. Med. Chem. Commun. 4(4), 737-740 (2013
    • (2013) Med. Chem. Commun , vol.4 , Issue.4 , pp. 737-740
    • Wang, Q.1    Wang, R.2    Zhang, B.3    Zhang, S.4    Zheng, Y.5    Wang, Z.6
  • 38
    • 77449109789 scopus 로고    scopus 로고
    • Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases
    • Bedford DC, Kasper LH, Fukuyama T, Brindle PK. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5(1), 9-15 (2010
    • (2010) Epigenetics , vol.5 , Issue.1 , pp. 9-15
    • Bedford, D.C.1    Kasper, L.H.2    Fukuyama, T.3    Brindle, P.K.4
  • 39
    • 10744233648 scopus 로고    scopus 로고
    • Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation
    • Mujtaba S, He Y, Zeng L et al. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol. Cell. 13(2), 251-263 (2004
    • (2004) Mol. Cell , vol.13 , Issue.2 , pp. 251-263
    • Mujtaba, S.1    He, Y.2    Zeng, L.3
  • 40
    • 79955410483 scopus 로고    scopus 로고
    • A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes
    • Borah JC, Mujtaba S, Karakikes I et al. A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem. Biol. 18(4), 531-541 (2011
    • (2011) Chem. Biol , vol.18 , Issue.4 , pp. 531-541
    • Borah, J.C.1    Mujtaba, S.2    Karakikes, I.3
  • 41
    • 84884238437 scopus 로고    scopus 로고
    • Discovery, design, and optimization of isoxazole azepine BET inhibitors
    • Gehling VS, Hewitt MC, Vaswani RG et al. Discovery, design, and optimization of isoxazole azepine BET inhibitors. ACS Med. Chem. Lett. 4(9), 835-840 (2013
    • (2013) ACS Med. Chem. Lett , vol.4 , Issue.9 , pp. 835-840
    • Gehling, V.S.1    Hewitt, M.C.2    Vaswani, R.G.3
  • 42
    • 80052728034 scopus 로고    scopus 로고
    • Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
    • Philpott M, Yang J, Tumber T et al. Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. Mol. BioSyst. 7(10), 2899-2908 (2011
    • (2011) Mol. BioSyst , vol.7 , Issue.10 , pp. 2899-2908
    • Philpott, M.1    Yang, J.2    Tumber, T.3
  • 43
    • 1942453243 scopus 로고    scopus 로고
    • Ligand efficiency: A useful metric for lead selection
    • Hopkins AL, Groom CR, Alex A. Ligand efficiency: A useful metric for lead selection. Drug Discov. Today. 9(10), 430-431 (2004
    • (2004) Drug Discov. Today , vol.9 , Issue.10 , pp. 430-431
    • Hopkins, A.L.1    Groom, C.R.2    Alex, A.3
  • 44
    • 84878565710 scopus 로고    scopus 로고
    • PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains
    • Picaud S, Da Costa D, Thanasopoulou A et al. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains. Cancer Res. 73(11), 3336-3346 (2013
    • (2013) Cancer Res , vol.73 , Issue.11 , pp. 3336-3346
    • Picaud, S.1    Da Costa, D.2    Thanasopoulou, A.3
  • 45
    • 84886504602 scopus 로고    scopus 로고
    • Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening
    • Vidler LR, Filippakopoulos P, Fedorov O et al. Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening. J. Med. Chem. 56(20), 8073-8088 (2013
    • (2013) J. Med. Chem , vol.56 , Issue.20 , pp. 8073-8088
    • Vidler, L.R.1    Filippakopoulos, P.2    Fedorov, O.3
  • 46
    • 79953703975 scopus 로고    scopus 로고
    • Fragment screening to predict druggability (ligandability) and lead discovery success
    • Edfeldt FNB, Folmer RHA, Breeze AL. Fragment screening to predict druggability (ligandability) and lead discovery success. Drug Discov. Today 16(7-8), 284-287 (2011
    • (2011) Drug Discov. Today , vol.16 , Issue.7-8 , pp. 284-287
    • Edfeldt, F.N.B.1    Folmer, R.H.A.2    Breeze, A.L.3
  • 47
    • 79952005101 scopus 로고    scopus 로고
    • Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-Treated patients with stable coronary artery disease a randomized controlled trial
    • Nicholls SJ, Gordon A, Johansson J et al. Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-Treated patients with stable coronary artery disease a randomized controlled trial. J. Am. Coll. Cardiol. 57(9), 1111-1119 (2011
    • (2011) J. Am. Coll. Cardiol , vol.57 , Issue.9 , pp. 1111-1119
    • Nicholls, S.J.1    Gordon, A.2    Johansson, J.3
  • 48
    • 84862765834 scopus 로고    scopus 로고
    • ApoA-I induction as a potential cardioprotective strategy: Rationale for the SUSTAIN and ASSURE studies
    • Nicholls SJ, Gordon A, Johannson J et al. ApoA-I induction as a potential cardioprotective strategy: Rationale for the SUSTAIN and ASSURE studies. Cardiovasc Drugs Ther. 26(2), 181-187 (2012
    • (2012) Cardiovasc Drugs Ther , vol.26 , Issue.2 , pp. 181-187
    • Nicholls, S.J.1    Gordon, A.2    Johannson, J.3
  • 49
    • 0026580006 scopus 로고
    • Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2
    • Tamkun JW, Deuring R, Scott MP et al. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68(3), 561-572 (1992
    • (1992) Cell , vol.68 , Issue.3 , pp. 561-572
    • Tamkun, J.W.1    Deuring, R.2    Scott, M.P.3
  • 51
    • 17444386662 scopus 로고    scopus 로고
    • The bromodomain: A chromatin-Targeting module?
    • Winston F, Allis C. The bromodomain: A chromatin-Targeting module? Nat. Struct. Biol. 6(7), 601-604 (1999
    • (1999) Nat. Struct. Biol , vol.6 , Issue.7 , pp. 601-604
    • Winston, F.1    Allis, C.2
  • 52
    • 84859926557 scopus 로고    scopus 로고
    • Small molecule bromodomain inhibitors: Extending the druggable genome
    • Chung C-W. Small molecule bromodomain inhibitors: Extending the druggable genome. Prog. Med. Chem. 51, 1-55 (2012
    • (2012) Prog. Med. Chem , vol.51 , pp. 1-55
    • Chung, C.-W.1
  • 53
    • 80055000824 scopus 로고    scopus 로고
    • RNAi screen identifies BRD4 as a therapeutic target in acute myeloid leukemia
    • Zuber J, Shi J, Wang E et al. RNAi screen identifies BRD4 as a therapeutic target in acute myeloid leukemia. Nature 478(7370), 524-528 (2011
    • (2011) Nature , vol.478 , Issue.7370 , pp. 524-528
    • Zuber, J.1    Shi, J.2    Wang, E.3
  • 54
    • 80053651202 scopus 로고    scopus 로고
    • Targeting MYC dependence in cancer by inhibiting BET bromodomains
    • Mertz JA, Conery AR, Bryant BM et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl Acad. Sci. USA 108(40), 16669-16674 (2011
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , Issue.40 , pp. 16669-16674
    • Mertz, J.A.1    Conery, A.R.2    Bryant, B.M.3
  • 55
    • 70450169243 scopus 로고    scopus 로고
    • Inhibition of protein-protein interactions using designed molecules
    • Wilson AJ. Inhibition of protein-protein interactions using designed molecules. Chem. Soc. Rev. 38(12), 3289-3300 (2009
    • (2009) Chem. Soc. Rev , vol.38 , Issue.12 , pp. 3289-3300
    • Wilson, A.J.1
  • 56
    • 84866338076 scopus 로고    scopus 로고
    • Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites
    • Vidler LR, Brown N, Knapp S, Hoelder S. Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites. J. Med. Chem. 55(17), 7346-7359 (2012
    • (2012) J. Med. Chem , vol.55 , Issue.17 , pp. 7346-7359
    • Vidler, L.R.1    Brown, N.2    Knapp, S.3    Hoelder, S.4
  • 57
    • 84866314665 scopus 로고    scopus 로고
    • Scaling the druggability landscape of human bromodomains, a new class of drug targets
    • Zhang G, Sanchez R, Zhou M-M. Scaling the druggability landscape of human bromodomains, a new class of drug targets. J. Med. Chem. 55(17), 7342-7345 (2012
    • (2012) J. Med. Chem , vol.55 , Issue.17 , pp. 7342-7345
    • Zhang, G.1    Sanchez, R.2    Zhou, M.-M.3
  • 59
    • 84885675970 scopus 로고    scopus 로고
    • Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains
    • Mirguet O, Gosmini R, Toum J et al. Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains. J. Med. Chem. 56(19), 7501-7515 (2013
    • (2013) J. Med. Chem , vol.56 , Issue.19 , pp. 7501-7515
    • Mirguet, O.1    Gosmini, R.2    Toum, J.3
  • 60
    • 35748934487 scopus 로고    scopus 로고
    • The influence of drug-like concepts on decision-making in medicinal chemistry
    • Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Disc. 6(11), 881-890 (2007
    • (2007) Nat. Rev. Drug Disc , vol.6 , Issue.11 , pp. 881-890
    • Leeson, P.D.1    Springthorpe, B.2
  • 61
    • 84865229469 scopus 로고    scopus 로고
    • Small-molecule inhibition of BRDT for male contraception
    • Matzuk MM, McKeown MR, Filippakopoulos P et al. Small-molecule inhibition of BRDT for male contraception. Cell 150(4), 673-684 (2012
    • (2012) Cell , vol.150 , Issue.4 , pp. 673-684
    • Matzuk, M.M.1    McKeown, M.R.2    Filippakopoulos, P.3
  • 62
    • 84876033650 scopus 로고    scopus 로고
    • Targeting MYCN in neuroblastoma by BET bromodomain inhibition
    • Puissant A, Frumm SM, Alexe G et al. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 3(3), 308-323 (2013
    • (2013) Cancer Discov , vol.3 , Issue.3 , pp. 308-323
    • Puissant, A.1    Frumm, S.M.2    Alexe, G.3
  • 63
    • 84870708220 scopus 로고    scopus 로고
    • Stability of nucleosomes containing homogenously ubiquitylated H2A and H2B prepared using semisynthesis
    • Fierz B, Kilic S, Hieb AR, Luger K, Muir TW. Stability of nucleosomes containing homogenously ubiquitylated H2A and H2B prepared using semisynthesis. J. Am. Chem. Soc. 134(48), 19548-19551 (2012
    • (2012) J. Am. Chem. Soc , vol.134 , Issue.48 , pp. 19548-19551
    • Fierz, B.1    Kilic, S.2    Hieb, A.R.3    Luger, K.4    Muir, T.W.5
  • 64
    • 77954821594 scopus 로고    scopus 로고
    • What an epigenome remembers
    • Lange UC, Schneider R. What an epigenome remembers. Bioessays 32(8), 659-668 (2010
    • (2010) Bioessays , vol.32 , Issue.8 , pp. 659-668
    • Lange, U.C.1    Schneider, R.2
  • 65
    • 79956140184 scopus 로고    scopus 로고
    • Getting pharmaceutical R&D back on target
    • Bunnage ME. Getting pharmaceutical R&D back on target. Nat. Chem. Biol. 7(6), 335-339 (2011
    • (2011) Nat. Chem. Biol , vol.7 , Issue.6 , pp. 335-339
    • Bunnage, M.E.1
  • 66
    • 0037138363 scopus 로고    scopus 로고
    • Bromodomain: An acetyl-lysine binding domain
    • Zeng L, Zhou M. Bromodomain: An acetyl-lysine binding domain. FEBS Lett. 513(1), 124-128 (2002
    • (2002) FEBS Lett , vol.513 , Issue.1 , pp. 124-128
    • Zeng, L.1    Zhou, M.2
  • 67
    • 84864578590 scopus 로고    scopus 로고
    • The bromodomain interaction module
    • Filippakopoulos P, Knapp S. The bromodomain interaction module. FEBS Lett. 586(17), 2692-2704 (2012
    • (2012) FEBS Lett , vol.586 , Issue.17 , pp. 2692-2704
    • Filippakopoulos, P.1    Knapp, S.2
  • 68
    • 0016211838 scopus 로고
    • Chromatin structure; oligomers of the histones
    • Kornberg RD, Thomas JO. Chromatin structure; oligomers of the histones. Science 184(4139), 865-868 (1974
    • (1974) Science , vol.184 , Issue.4139 , pp. 865-868
    • Kornberg, R.D.1    Thomas, J.O.2
  • 69
    • 0016221697 scopus 로고
    • Chromatin structure: A repeating unit of histones and DNA
    • Kornberg RD. Chromatin structure: A repeating unit of histones and DNA. Science 184(4139), 868-871 (1974
    • (1974) Science , vol.184 , Issue.4139 , pp. 868-871
    • Kornberg, R.D.1
  • 70
    • 1842411320 scopus 로고    scopus 로고
    • Crystal structure of the nucleosome core particle at 2.8 Å resolution
    • Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389(6648), 251-260 (1997
    • (1997) Nature , vol.389 , Issue.6648 , pp. 251-260
    • Luger, K.1    Mäder, A.W.2    Richmond, R.K.3    Sargent, D.F.4    Richmond, T.J.5
  • 71
    • 78651162036 scopus 로고
    • Acetylation and Methylation of Histones and their Possible Role in Regulation of RNA Synthesis
    • Allfrey V, Faulkner R, Mirsky A. Acetylation and Methylation of Histones and their Possible Role in Regulation of RNA Synthesis. Proc. Natl Acad. Sci. USA 51(5), 786-794 (1964
    • (1964) Proc. Natl Acad. Sci. USA , vol.51 , Issue.5 , pp. 786-794
    • Allfrey, V.1    Faulkner, R.2    Mirsky, A.3
  • 72
    • 0034610814 scopus 로고    scopus 로고
    • The language of covalent histone modifications
    • Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403(6765), 41-45 (2000
    • (2000) Nature , vol.403 , Issue.6765 , pp. 41-45
    • Strahl, B.D.1    Allis, C.D.2
  • 73
    • 0033848849 scopus 로고    scopus 로고
    • Histone acetylation and an epigenetic code
    • Turner BM. Histone acetylation and an epigenetic code. Bioessays 22(9), 836-845 (2000
    • (2000) Bioessays , vol.22 , Issue.9 , pp. 836-845
    • Turner, B.M.1
  • 74
    • 0037074010 scopus 로고    scopus 로고
    • Signaling network model of chromatin
    • Schreiber SL, Bernstein BE. Signaling network model of chromatin. Cell 111(6), 771-778 (2002
    • (2002) Cell , vol.111 , Issue.6 , pp. 771-778
    • Schreiber, S.L.1    Bernstein, B.E.2
  • 75
    • 79955473684 scopus 로고    scopus 로고
    • Operating on chromatin, a colorful language where context matters
    • Gardner KE, Allis CD, Strahl BD. Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 409(1), 36-46 (2011
    • (2011) J. Mol. Biol , vol.409 , Issue.1 , pp. 36-46
    • Gardner, K.E.1    Allis, C.D.2    Strahl, B.D.3
  • 76
    • 0030798245 scopus 로고    scopus 로고
    • Histone acetylation in chromatin structure and transcription
    • Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389(6649), 349-352 (1997
    • (1997) Nature , vol.389 , Issue.6649 , pp. 349-352
    • Grunstein, M.1
  • 77
    • 0035839136 scopus 로고    scopus 로고
    • Translating the histone code
    • Jenuwein T, Allis CD. Translating the histone code. Science 293(5532), 1074-1080 (2001
    • (2001) Science , vol.293 , Issue.5532 , pp. 1074-1080
    • Jenuwein, T.1    Allis, C.D.2
  • 78
    • 0036849072 scopus 로고    scopus 로고
    • Global approaches to chromatin
    • Bernstein BE, Schreiber SL. Global approaches to chromatin. Chem. Biol. 9(11), 1167-1173 (2002
    • (2002) Chem. Biol , vol.9 , Issue.11 , pp. 1167-1173
    • Bernstein, B.E.1    Schreiber, S.L.2
  • 79
    • 84865179248 scopus 로고    scopus 로고
    • The adjustable nucleosome: An epigenetic signaling module
    • Turner BM. The adjustable nucleosome: An epigenetic signaling module. Trends Genet. 28(9), 436-444 (2012
    • (2012) Trends Genet , vol.28 , Issue.9 , pp. 436-444
    • Turner, B.M.1
  • 80
    • 34249337761 scopus 로고    scopus 로고
    • Perceptions of epigenetics
    • Bird A. Perceptions of epigenetics. Nature 447(7143), 396-398 (2007
    • (2007) Nature , vol.447 , Issue.7143 , pp. 396-398
    • Bird, A.1
  • 81
    • 84876888289 scopus 로고    scopus 로고
    • Epigenetics: Core misconcept
    • Ptashne M. Epigenetics: Core misconcept. Proc. Natl Acad. Sci. USA 110(18), 7101-7103 (2013
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , Issue.18 , pp. 7101-7103
    • Ptashne, M.1
  • 82
    • 67049134843 scopus 로고    scopus 로고
    • How to achieve confidence in drug discovery and development: Managing risk (from a reductionist to a holistic approach
    • Bakker A, Caricasole A, Gaviraghi G et al. How to achieve confidence in drug discovery and development: Managing risk (from a reductionist to a holistic approach). ChemMedChem 4(6), 923-933 (2009
    • (2009) ChemMedChem , vol.4 , Issue.6 , pp. 923-933
    • Bakker, A.1    Caricasole, A.2    Gaviraghi, G.3
  • 84
    • 84881296154 scopus 로고    scopus 로고
    • Trial watch: Phase ii and phase iii attrition rates 2011-2012
    • Arrowsmith J, Miller P. Trial Watch: Phase II and Phase III attrition rates 2011-2012. Nat. Rev. Drug Disc. 12(8), 569 (2013
    • (2013) Nat. Rev. Drug Disc , vol.12 , Issue.8 , pp. 569
    • Arrowsmith, J.1    Miller, P.2
  • 86
    • 46849089254 scopus 로고    scopus 로고
    • Recent developments in fragment-based drug discovery
    • Congreve M, Chessari G, Tisi D, Woodhead AJ. Recent developments in fragment-based drug discovery. J. Med. Chem. 51(13), 3661-3680 (2008
    • (2008) J. Med. Chem , vol.51 , Issue.13 , pp. 3661-3680
    • Congreve, M.1    Chessari, G.2    Tisi, D.3    Woodhead, A.J.4
  • 87
    • 0141726877 scopus 로고    scopus 로고
    • A rule of threé for fragment-based lead discovery?
    • Congreve M, Carr R, Murray C, Jhoti H. A rule of threé for fragment-based lead discovery? Drug Discov. Today 8(19), 876-877 (2003
    • (2003) Drug Discov. Today , vol.8 , Issue.19 , pp. 876-877
    • Congreve, M.1    Carr, R.2    Murray, C.3    Jhoti, H.4
  • 88
    • 84862869077 scopus 로고    scopus 로고
    • Fragment-based approaches in drug discovery and chemical biology
    • Scott DE, Coyne AG, Hudson SA, Abell C. Fragment-based approaches in drug discovery and chemical biology. Biochemistry 51(25), 4990-5003 (2012
    • (2012) Biochemistry , vol.51 , Issue.25 , pp. 4990-5003
    • Scott, D.E.1    Coyne, A.G.2    Hudson, S.A.3    Abell, C.4
  • 89
    • 84874414338 scopus 로고    scopus 로고
    • Fragment-based lead discovery grows up
    • Baker M. Fragment-based lead discovery grows up. Nat. Rev. Drug Disc. 12(1), 5-7 (2013
    • (2013) Nat. Rev. Drug Disc , vol.12 , Issue.1 , pp. 5-7
    • Baker, M.1
  • 90
    • 84868475728 scopus 로고    scopus 로고
    • MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles
    • van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat. Rev. Drug Disc. 11(11), 860-872 (2012
    • (2012) Nat. Rev. Drug Disc , vol.11 , Issue.11 , pp. 860-872
    • Van Rooij, E.1    Olson, E.N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.